Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

Mette Ilander,Ulla Olsson-Strömberg,Hanna Lahteenmaki,Tiina Kasanen,Perttu Koskenvesa,Stina Söderlund,Martin Höglund,Berit Markevärn,Anders Själander,Kouros Lofti,Claes Malm,Anna Lübking,Marja Ekblom,Elena Holm,Mats Björeman,Sören Lehmann,Leif Stenke,Lotta Ohm,Henrik Hjorth-Hansen,Susanne Saussele,François-Xavier Mahon,Kimmo Porkka,Johan Richter,Satu Mustjoki

Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

2014

Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

Keywords:

Immunology
Discontinuation
Tyrosine-kinase inhibitor
Myeloid
DISEASE RELAPSE
Medicine
chronic myeloid leukaemia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations